These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 2530794

  • 21. Meta-analysis of early phase II studies with paroxetine in hospitalized depressed patients.
    Byrne MM.
    Acta Psychiatr Scand Suppl; 1989; 350():138-9. PubMed ID: 2530768
    [No Abstract] [Full Text] [Related]

  • 22. Platelet 5-HT transport in depressed patients under double-blind treatment with paroxetine versus amitriptyline.
    Schlake HP, Kuhs H, Rolf LH, Bosse T, Schuhknecht E, Rudolf GA, Brune GG.
    Acta Psychiatr Scand Suppl; 1989; 350():149-51. PubMed ID: 2530775
    [No Abstract] [Full Text] [Related]

  • 23. Introduction to the development of paroxetine, a novel antidepressant.
    Lassen JB.
    Acta Psychiatr Scand Suppl; 1989; 350():13. PubMed ID: 2530764
    [No Abstract] [Full Text] [Related]

  • 24. The efficacy and safety of paroxetine compared with placebo in outpatients with major depression.
    Rickels K, Amsterdam J, Clary C, Fox I, Schweizer E, Weise C.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():30-2. PubMed ID: 1531820
    [Abstract] [Full Text] [Related]

  • 25. The effect of paroxetine on the electroencephalogram, electrocardiogram, and blood pressure.
    Edwards JG, Goldie A, Papayanni-Papasthatis S, Punter J, Sedgwick EM.
    Acta Psychiatr Scand Suppl; 1989 Feb; 350():124. PubMed ID: 2530762
    [No Abstract] [Full Text] [Related]

  • 26. A double-blind, placebo-controlled study of paroxetine in depressed outpatients.
    Kiev A.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():27-9. PubMed ID: 1531818
    [Abstract] [Full Text] [Related]

  • 27. First results of an open phase II study with the antidepressant paroxetine.
    Stuppäck C, Schubert H, Barnas C, Mair M, Schifferle I, Unterweger B, Wömhart L, Fleischhacker WW, Hinterhuber H.
    Pharmacopsychiatry; 1988 Nov; 21(6):369-70. PubMed ID: 2977442
    [No Abstract] [Full Text] [Related]

  • 28. An overview of paroxetine.
    Boyer WF, Feighner JP.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():3-6. PubMed ID: 1531819
    [Abstract] [Full Text] [Related]

  • 29. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.
    Dunner DL, Cohn JB, Walshe T, Cohn CK, Feighner JP, Fieve RR, Halikas JP, Hartford JT, Hearst ED, Settle EC.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():57-60. PubMed ID: 1531827
    [Abstract] [Full Text] [Related]

  • 30. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP, Boyer WF.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
    [Abstract] [Full Text] [Related]

  • 31. The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor.
    Tulloch IF, Johnson AM.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():7-12. PubMed ID: 1531829
    [Abstract] [Full Text] [Related]

  • 32. The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients.
    Claghorn JL.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():33-5. PubMed ID: 1531821
    [Abstract] [Full Text] [Related]

  • 33. New antidepressants and 5-HT uptake inhibitors.
    Montgomery SA.
    Acta Psychiatr Scand Suppl; 1989 Feb; 350():107-16. PubMed ID: 2530760
    [Abstract] [Full Text] [Related]

  • 34. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
    Fabre LF.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
    [Abstract] [Full Text] [Related]

  • 35. Concentration-response relationship in paroxetine treatment of diabetic neuropathy symptoms: a patient-blinded dose-escalation study.
    Sindrup SH, Grodum E, Gram LF, Beck-Nielsen H.
    Ther Drug Monit; 1991 Sep; 13(5):408-14. PubMed ID: 1835549
    [Abstract] [Full Text] [Related]

  • 36. The pharmacokinetics of paroxetine in the elderly.
    Bayer AJ, Roberts NA, Allen EA, Horan M, Routledge PA, Swift CG, Byrne MM, Clarkson A, Zussman BD.
    Acta Psychiatr Scand Suppl; 1989 Sep; 350():85-6. PubMed ID: 2530796
    [No Abstract] [Full Text] [Related]

  • 37. Paroxetine in the treatment of depression--a randomized comparison with amitriptyline.
    Laursen AL, Mikkelsen PL, Rasmussen S, le Fèvre Honoré P.
    Acta Psychiatr Scand; 1985 Mar; 71(3):249-55. PubMed ID: 3157296
    [Abstract] [Full Text] [Related]

  • 38. Plasma ratio tryptophan/neutral amino acids in relation to clinical response to paroxetine and clomipramine in patients with major depression.
    Møller SE, Bech P, Bjerrum H, Bøjholm S, Butler B, Folker H, Gram LF, Larsen JK, Lauritzen L, Loldrup D.
    J Affect Disord; 1990 Jan; 18(1):59-66. PubMed ID: 2136870
    [Abstract] [Full Text] [Related]

  • 39. Paroxetine: an overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatment of depression.
    Nemeroff CB.
    J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):10S-17S. PubMed ID: 8106649
    [Abstract] [Full Text] [Related]

  • 40. The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo.
    Peselow ED, Filippi AM, Goodnick P, Barouche F, Fieve RR.
    Psychopharmacol Bull; 1989 Dec; 25(2):267-71. PubMed ID: 2532373
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.